MedTrace Logo

Cell Therapy in Advanced Chronic Obstructive Pulmonary Disease Patients

NCT02412332 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2016-05-24

No results posted yet for this study

Summary

The purpose of this study is to determine whether cell therapy with autologous adult stem cells (from bone marrow and/or fat) is safe in the treatment of advanced Chronic Obstructive Pulmonary Disease (COPD).

Conditions

  • Chronic Obstructive Pulmonary Disease (COPD)

Interventions

PROCEDURE

Bone marrow harvesting

Approximately 200 mL of bone marrow will be surgically collect from the iliac crest (pelvis) of the patient under spinal anesthesia.

PROCEDURE

Liposuction

Approximately 50 mL of adipose tissue (fat) will be surgically collected from the abdominal region of the patient under spinal anesthesia.

Sponsors & Collaborators

  • Faculdade de Medicina do ABC

    collaborator OTHER

  • IEP São Lucas - Instituto de Ensino e Pesquisa

    collaborator OTHER

  • Hemocentro São Lucas

    collaborator UNKNOWN

  • CordCell

    collaborator UNKNOWN

  • UPECLIN HC FM Botucatu Unesp

    lead OTHER

Principal Investigators

  • Selma D Squassoni, MD · Faculdade de Medicina do ABC

  • Ellie Fiss, MD · Faculdade de Medicina do ABC

  • Elíseo J Sekya · IEP São Lucas - Instituto de Ensino e Pesquisa

  • Adelson Alves, Dr · Hemocentro São Lucas

  • Andressa Forte · TechLife

  • Larissa C Zanutto · IEP São Lucas - Instituto de Ensino e Pesquisa

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2016-10-31
Completion
2017-04-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02412332 on ClinicalTrials.gov